Loading company details...
Beta
Latest Form 4 (Oct 2, 2024): Richard A. Colvin (Chief Medical Officer): Grant/Award of 50,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2024 | Richard A. Colvin, Chief Medical Officer | Grant/Award | 50,000 | n/a |
| Oct 2, 2024 | Joseph Vittiglio, Chief Business & Legal Officer | Grant/Award | 50,000 | n/a |
| Oct 2, 2024 | O. James Sterling, Chief Financial Officer | Grant/Award | 100,000 | n/a |
| Oct 2, 2024 | Michael Cloonan | Grant/Award | 37,350 | n/a |
| Oct 2, 2024 | Thomas J. Klima, Chief Commercial & Operating Officer | Grant/Award | 50,000 | n/a |
| Oct 2, 2024 | Andrew Obenshain, President and CEO | Grant/Award | 130,000 | n/a |
| Jul 3, 2024 | O. James Sterling, Chief Financial Officer | Grant/Award | 300,000 | n/a |
| Jun 24, 2024 | Michael Cloonan | Grant/Award | 74,775 | n/a |
| Jun 4, 2024 | Thomas J. Klima, Chief Commercial & Operating Officer | Sale | 3,834 | $3.7K |
| Mar 5, 2024 | Richard A. Colvin, Chief Medical Officer | Sale | 6,770 | $10.3K |